← Leaderboards
Gillian Jane McLellan
University Of Wisconsin-Madison
$4,550,322
Attributed
$4,966,769
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $941.2K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,966,769 · 8
By mechanism
R01$2,045,402 · 1
R21$1,674,826 · 4
K08$859,778 · 1
S10$210,000 · 1
P30$176,763 · 1
Top collaborators
- Jeremy D. Rogers2 shared
- Weiming Mao1 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- David M Gamm$16,807,477
- Stuart William James Tompson$427,625
Others in their field
Top investigators on “Glaucoma”
- Rohit Varma · University Of Southern California$58,233,961
- Janey L Wiggs · Massachusetts Eye And Ear Infirmary$36,083,461
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- David Huang · Cleveland Clinic Lerner Col/Med-Cwru$27,740,623
- Linda M Zangwill · University Of California San Diego$23,025,291
- Robert N Weinreb · University Of California, San Diego$21,784,031
Research focus
GlaucomaAnimal ModelIn VivoPhysiologic Intraocular PressureFelis CatusBlindnessPathway InteractionsAffectDisease ProgressionStructureFunctional DisorderOptic Nerve DisorderFamily FelidaeTreatment StrategyOptic NerveVisualTranslationsFoundationsAnimalsPathologyExtracellular MatrixElectrophysiology (Science)PlayPathologic
Grant awards (19)
Targeting TGFBeta-mediated IOP dysregulation in a large animal model of glaucoma$439,016
R21 · FY2025 · EY · contact PI
The role of LTBP2 in glaucoma$194,375
R21 · FY2024 · EY · contact PI
The role of LTBP2 in glaucoma$233,250
R21 · FY2023 · EY · contact PI
Disease Mechanisms at the Intersection of Glaucoma and Alzheimer's Disease$414,306
R21 · FY2021 · AG · contact PI
Therapeutic Inhibition of Optic Nerve Head Gliosis and Fibrosis in Glaucoma$350,149
R01 · FY2021 · EY · contact PI
UW Vision Research Core 3 - Animal Models and Eye Organ Culture$176,763
P30 · FY2021 · EY · contact PI
Therapeutic Inhibition of Optic Nerve Head Gliosis and Fibrosis in Glaucoma$368,658
R01 · FY2020 · EY · contact PI
Shared risk and pathology in Alzheimer's disease and glaucoma$181,533
R01 · FY2020 · EY · contact PI
Therapeutic Inhibition of Optic Nerve Head Gliosis and Fibrosis in Glaucoma$380,457
R01 · FY2019 · EY · contact PI
Enhanced backscattering instrument for assessing optical biomarkers of glaucoma$184,890
R21 · FY2019 · EB
Therapeutic Inhibition of Optic Nerve Head Gliosis and Fibrosis in Glaucoma$382,105
R01 · FY2018 · EY · contact PI
Enhanced backscattering instrument for assessing optical biomarkers of glaucoma$208,989
R21 · FY2018 · EB
Therapeutic Inhibition of Optic Nerve Head Gliosis and Fibrosis in Glaucoma$382,500
R01 · FY2017 · EY · contact PI
Spectral domain optical coherence tomography instrument for multimodal imaging$210,000
S10 · FY2014 · OD · contact PI
Structural and Functional Characterization of a Novel Model for Glaucoma Research$177,101
K08 · FY2012 · EY · contact PI
Structural and Functional Characterization of a Novel Model for Glaucoma Research$177,101
K08 · FY2011 · EY · contact PI
Structural and Functional Characterization of a Novel Model for Glaucoma Research$172,729
K08 · FY2010 · EY · contact PI
Structural and Functional Characterization of a Novel Model for Glaucoma Research$168,484
K08 · FY2009 · EY · contact PI
Structural and Functional Characterization of a Novel Model for Glaucoma Research$164,363
K08 · FY2008 · EY · contact PI